Evidence map›Paper›PMID 42653737›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

System Performance Check (SPC): A Readiness Companion to Multi-Attribute Method (MAM) Analysis in Biopharmaceutical Quality Control.

Jahziel Chase, Melissa Sato, Gordon Slysz, Mahsan Miladi, Mike Knierman, Robert Barkovich, Jared Auclair

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jahziel ChaseCenter of Bio-Innovation, Northeastern University, 147 South Bedford Street, Burlington, MA 01803, USA.ORCID 0000-0002-0140-4205
Melissa SatoAgilent Technologies, Inc., Santa Clara, CA 95051, USA.
Gordon SlyszAgilent Technologies, Inc., Santa Clara, CA 95051, USA.
Mahsan MiladiAgilent Technologies, Inc., Santa Clara, CA 95051, USA.
Mike KniermanAgilent Technologies, Inc., Santa Clara, CA 95051, USA.ORCID 0000-0001-7427-2269
Robert BarkovichAgilent Technologies, Inc., Santa Clara, CA 95051, USA.
Jared AuclairCenter of Bio-Innovation, Northeastern University, 147 South Bedford Street, Burlington, MA 01803, USA.ORCID 0000-0002-3094-1544

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biopharmaceutical quality controlcritical quality attributesLC-MSmass spectrometrymulti-attribute methodpeptide mappingsystem performance checksystem suitabilityUSP 1060

Identifiers

PMID42653737
PMCPMC13517073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.